vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $66.7M, roughly 14.2× RMR GROUP INC.). RMR GROUP INC. runs the higher net margin — 18.3% vs 0.7%, a 17.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 40.8%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

ASTH vs RMR — Head-to-Head

Bigger by revenue
ASTH
ASTH
14.2× larger
ASTH
$950.5M
$66.7M
RMR
Growing faster (revenue YoY)
ASTH
ASTH
+2.1% gap
ASTH
42.9%
40.8%
RMR
Higher net margin
RMR
RMR
17.6% more per $
RMR
18.3%
0.7%
ASTH

Income Statement — Q4 2025 vs Q1 2026

Metric
ASTH
ASTH
RMR
RMR
Revenue
$950.5M
$66.7M
Net Profit
$6.6M
$12.2M
Gross Margin
Operating Margin
1.9%
48.1%
Net Margin
0.7%
18.3%
Revenue YoY
42.9%
40.8%
Net Profit YoY
184.4%
91.1%
EPS (diluted)
$0.12
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
RMR
RMR
Q4 25
$950.5M
$66.7M
Q3 25
$956.0M
Q2 25
$654.8M
Q1 25
$620.4M
Q4 24
$665.2M
Q3 24
$478.7M
Q2 24
$486.3M
Q1 24
$404.4M
Net Profit
ASTH
ASTH
RMR
RMR
Q4 25
$6.6M
$12.2M
Q3 25
$373.0K
Q2 25
$9.4M
Q1 25
$6.7M
Q4 24
$-7.8M
Q3 24
$16.1M
Q2 24
$19.2M
Q1 24
$14.8M
Operating Margin
ASTH
ASTH
RMR
RMR
Q4 25
1.9%
48.1%
Q3 25
2.0%
Q2 25
3.1%
Q1 25
3.3%
Q4 24
0.1%
Q3 24
5.9%
Q2 24
6.2%
Q1 24
7.5%
Net Margin
ASTH
ASTH
RMR
RMR
Q4 25
0.7%
18.3%
Q3 25
0.0%
Q2 25
1.4%
Q1 25
1.1%
Q4 24
-1.2%
Q3 24
3.4%
Q2 24
3.9%
Q1 24
3.7%
EPS (diluted)
ASTH
ASTH
RMR
RMR
Q4 25
$0.12
$0.71
Q3 25
$0.01
Q2 25
$0.19
Q1 25
$0.14
Q4 24
$-0.14
Q3 24
$0.33
Q2 24
$0.40
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$429.5M
$49.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$232.7M
Total Assets
$2.2B
$687.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
RMR
RMR
Q4 25
$429.5M
$49.3M
Q3 25
$463.4M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Q1 24
$337.3M
Stockholders' Equity
ASTH
ASTH
RMR
RMR
Q4 25
$779.3M
$232.7M
Q3 25
$775.5M
Q2 25
$765.5M
Q1 25
$745.4M
Q4 24
$712.7M
Q3 24
$704.6M
Q2 24
$678.9M
Q1 24
$653.5M
Total Assets
ASTH
ASTH
RMR
RMR
Q4 25
$2.2B
$687.1M
Q3 25
$2.2B
Q2 25
$1.4B
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
RMR
RMR
Operating Cash FlowLast quarter
$-2.9M
$10.7M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
0.88×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
RMR
RMR
Q4 25
$-2.9M
$10.7M
Q3 25
$10.0M
Q2 25
$90.9M
Q1 25
$16.6M
Q4 24
$-10.9M
Q3 24
$34.0M
Q2 24
$23.2M
Q1 24
$6.0M
Free Cash Flow
ASTH
ASTH
RMR
RMR
Q4 25
$-6.0M
Q3 25
$7.4M
Q2 25
$89.5M
Q1 25
$13.6M
Q4 24
$-13.5M
Q3 24
$31.7M
Q2 24
$20.4M
Q1 24
$5.6M
FCF Margin
ASTH
ASTH
RMR
RMR
Q4 25
-0.6%
Q3 25
0.8%
Q2 25
13.7%
Q1 25
2.2%
Q4 24
-2.0%
Q3 24
6.6%
Q2 24
4.2%
Q1 24
1.4%
Capex Intensity
ASTH
ASTH
RMR
RMR
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
0.6%
Q1 24
0.1%
Cash Conversion
ASTH
ASTH
RMR
RMR
Q4 25
-0.44×
0.88×
Q3 25
26.69×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons